skip to main content
Resultados 1 2 3 next page
Refinado por: Nome da Publicação: Clinical Lymphoma, Myeloma And Leukemia remover nível superior: Recursos Online remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Geriatric Assessment and Stratification
Material Type:
Artigo
Adicionar ao Meu Espaço

Geriatric Assessment and Stratification

Larocca, A

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e7-e7 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

2
Impact of complete response on progression-free survival and overall survival in newly diagnosed myeloma patients treated with autologous stem cell transplantation or conventional chemotherapy: results of a pooled analysis of 5 phase III trials
Material Type:
Artigo
Adicionar ao Meu Espaço

Impact of complete response on progression-free survival and overall survival in newly diagnosed myeloma patients treated with autologous stem cell transplantation or conventional chemotherapy: results of a pooled analysis of 5 phase III trials

Mina, R ; Larocca, A ; Offidani, M ; Magarotto, V ; Caravita, T ; van der Holt, R ; Di Raimondo, F ; Bosi, A ; Vincelli, I.D ; Croockewit, S ; Gaidano, G ; Grandi, S ; Musolino, C ; Cerrato, C ; Lud k, P ; Ruggeri, M ; Rossi, G ; Rossini, F ; Petrucci, M.T ; Ria, R ; Zweegman, S ; Hajek, R ; Spencer, A ; Boccadoro, M ; Sonneveld, P ; Palumbo, A

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e53-e54 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

3
Weekly Carfilzomib in combination with cyclophosphamide and dexamethasone (wCCyd) in patients (pts) with newly diagnosed Multiple Myeloma (NDMM): a phase 1/2 study of the European Myeloma Network Trialist Group
Material Type:
Artigo
Adicionar ao Meu Espaço

Weekly Carfilzomib in combination with cyclophosphamide and dexamethasone (wCCyd) in patients (pts) with newly diagnosed Multiple Myeloma (NDMM): a phase 1/2 study of the European Myeloma Network Trialist Group

Bringhen, S ; Gay, F ; Rossi, D ; Larocca, A ; Gentilini, F ; Galieni, P ; Malfitano, A ; Omedé, P ; Offidani, M ; Liberati, A.M ; Gaidano, G ; Boccadoro, M ; Sonneveld, P ; Corradini, P ; Palumbo, A

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e70-e70 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

4
Early Mortality in Elderly Patients With Newly Diagnosed Multiple Myeloma Treated With Novel Agents
Material Type:
Artigo
Adicionar ao Meu Espaço

Early Mortality in Elderly Patients With Newly Diagnosed Multiple Myeloma Treated With Novel Agents

Larocca, A ; Bringhen, S ; Petrucci, M.T ; Offidani, M ; Benevolo, G ; Galli, M ; Patriarca, F ; Ballanti, S ; Palladino, C ; Pescosta, N ; Grasso, M ; Evangelista, A ; Spada, S ; Pezzati, S ; Pulini, S ; Bernardini, A ; Rota-Scalabrini, D ; Morabito, F ; Tosi, P ; Oliva, S ; Baldini, M ; Marasca, R ; Finsinger, P ; Cellini, C ; Ria, R ; Aitoro, G ; Hajek, R ; Boccadoro, M ; Palumbo, A

Clinical lymphoma, myeloma and leukemia, 2015-09, Vol.15, p.e42-e43 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

5
P-392 Daratumumab-induced in vivo immune modulation in relapsed and/refractory multiple myeloma patients treated with daratumumab-len-dex
Material Type:
Artigo
Adicionar ao Meu Espaço

P-392 Daratumumab-induced in vivo immune modulation in relapsed and/refractory multiple myeloma patients treated with daratumumab-len-dex

Giannotta, Claudia ; Ziccheddu, Bachisio ; D'Agostino, Mattia ; Bertuglia, Giuseppe ; Saraci, Elona ; Oliva, Stefania ; Bolli, Niccolo' ; Landgren, Ola ; Bruno, Benedetto ; Boccadoro, Mario ; Maura, Francesco ; Massaia, Massimo ; Larocca, Alessandra

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S256-S257 [Periódico revisado por pares]

Texto completo disponível

6
OA-44 Pomalidomide, bortezomib, and dexamethasone vs bortezomib and dexamethasone in relapsed or refractory multiple myeloma (OPTIMISMM): final survival outcomes from a randomized, open-label, phase 3 trial
Material Type:
Artigo
Adicionar ao Meu Espaço

OA-44 Pomalidomide, bortezomib, and dexamethasone vs bortezomib and dexamethasone in relapsed or refractory multiple myeloma (OPTIMISMM): final survival outcomes from a randomized, open-label, phase 3 trial

Beksac, Meral ; Richardson, Paul ; Oriol, Albert ; Lindsay, Jindriska ; Schjesvold, Fredrik ; Galli, Monica ; Yağci, Münci ; Larocca, Alessandra ; Weisel, Katja ; Yu, Xin ; Donahue, Cynthia ; Acosta, Jorge ; Peluso, Teresa ; Dimopoulos, Meletios

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S27-S28 [Periódico revisado por pares]

Texto completo disponível

7
Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment
Material Type:
Artigo
Adicionar ao Meu Espaço

Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment

Oriol, Albert ; Dimopoulos, Meletios ; Schjesvold, Fredrik ; Beksac, Meral ; Facon, Thierry ; Dhanasiri, Sujith ; Guo, Shien ; Mu, Yutian ; Hong, Kevin ; Gentili, Christian ; Galli, Monica ; Yagci, Munci ; Larocca, Alessandra ; Richardson, Paul ; Weisel, Katja

Clinical lymphoma, myeloma and leukemia, 2024-03, Vol.24 (3), p.165-176.e4 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

8
P-253: Impact of adjusting bortezomib dose in the pomalidomide, bortezomib, and dexamethasone (PVd) combination: a post hoc analysis of the OPTIMISMM study
Material Type:
Artigo
Adicionar ao Meu Espaço

P-253: Impact of adjusting bortezomib dose in the pomalidomide, bortezomib, and dexamethasone (PVd) combination: a post hoc analysis of the OPTIMISMM study

Larocca, Alessandra ; Weisel, Katja ; Galli, Monica ; Oriol, Albert ; Facon, Thierry ; Dhanasiri, Sujith ; Hong, Kevin ; Gentili, Christian ; Mu, Yutian ; Guo, Shien ; Schjesvold, Fredrik ; Dimopoulos, Meletios A. ; Richardson, Paul

Clinical lymphoma, myeloma and leukemia, 2022-08, Vol.22, p.S175 [Periódico revisado por pares]

Texto completo disponível

9
Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment
Material Type:
Artigo
Adicionar ao Meu Espaço

Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment

Oriol, Albert ; Dimopoulos, Meletios ; Schjesvold, Fredrik Hellem ; Beksac, Meral ; Facon, Thierry ; Dhanasiri, Sujith ; Guo, Shien ; Mu, Yutian ; Hong, Kevin ; Gentili, Christian ; Galli, Monica ; Yagci, Munci ; Larocca, Alessandra ; Richardson, Paul ; Weisel, Katja

Clinical lymphoma, myeloma and leukemia, 2023 [Periódico revisado por pares]

CIG Media Group, LP

Texto completo disponível

10
P-191: The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: a systematic review
Material Type:
Artigo
Adicionar ao Meu Espaço

P-191: The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: a systematic review

Mian, Hira ; McCurdy, Arleigh ; Giri, Smith ; Grant, Shakira ; Rochwerg, Bram ; Winks, Erica ; Rosko, Ashley ; Engelhardt, Monika ; Pawlyn, Charlotte ; Cook, Gordon ; Jackson, Graham ; Brighen, Sara ; Facon, Thierry ; Larocca, Alessandra ; Zweegman, Sonja ; Wildes, Tanya

Clinical lymphoma, myeloma and leukemia, 2022-08, Vol.22, p.S140 [Periódico revisado por pares]

Texto completo disponível

Resultados 1 2 3 next page

Buscando em bases de dados remotas. Favor aguardar.